Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation
暂无分享,去创建一个
A. Gratwohl | D. Niederwieser | J. Passweg | T. Witte | B. Hertenstein | T. Ruutu | L. Garderet | A. Sureda | A. Biezen | A. Henseler | M. Mohty | A. Gratwohl | Tapani Ruutu | Bernd Hertenstein | Laurent Garderet | Mohamad Mohty | Anna Sureda
[1] R. Storb,et al. Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation. , 2011, Blood.
[2] J. Goldman,et al. Three decades of transplantation for chronic myeloid leukemia: what have we learned? , 2011, Blood.
[3] H. Einsele,et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 , 2010, Bone Marrow Transplantation.
[4] R. Brand,et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation , 2009, Cancer.
[5] A. Bacigalupo. Management of acute graft‐versus‐host disease , 2007, British journal of haematology.
[6] C. Raffoux,et al. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries , 2004, Bone Marrow Transplantation.
[7] Rachel L. Mistur,et al. Graft-Versus-Host Disease , 2016 .
[8] J. Sierra,et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia , 2000, The Lancet.
[9] G. Dini,et al. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. , 2000, Blood.
[10] A. Gratwohl,et al. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT) , 1997, Bone Marrow Transplantation.
[11] J. Goldman. A special report: bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee. , 1994, Blood.
[12] F. Frassoni,et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. , 1991, Blood.
[13] F. Appelbaum,et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.